In melanoma, FTO promotes cancer cell growth and suppresses the effects of anti-PD-1 blockade immunotherapy, and inhibition of FTO in glioma suppresses cancer stem cell growth and self-renewal66,71. This evidence concerns the gene FTO and melanoma.